JP2015529327A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529327A5
JP2015529327A5 JP2015528457A JP2015528457A JP2015529327A5 JP 2015529327 A5 JP2015529327 A5 JP 2015529327A5 JP 2015528457 A JP2015528457 A JP 2015528457A JP 2015528457 A JP2015528457 A JP 2015528457A JP 2015529327 A5 JP2015529327 A5 JP 2015529327A5
Authority
JP
Japan
Prior art keywords
ratio
positive correlation
correlation
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528457A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529327A (ja
JP6153613B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/031812 external-priority patent/WO2014031164A1/en
Publication of JP2015529327A publication Critical patent/JP2015529327A/ja
Publication of JP2015529327A5 publication Critical patent/JP2015529327A5/ja
Application granted granted Critical
Publication of JP6153613B2 publication Critical patent/JP6153613B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528457A 2012-08-23 2013-03-15 乳がん治療を決定する方法 Expired - Fee Related JP6153613B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261692331P 2012-08-23 2012-08-23
US61/692,331 2012-08-23
PCT/US2013/031812 WO2014031164A1 (en) 2012-08-23 2013-03-15 Method for determining breast cancer treatment

Publications (3)

Publication Number Publication Date
JP2015529327A JP2015529327A (ja) 2015-10-05
JP2015529327A5 true JP2015529327A5 (enExample) 2016-01-28
JP6153613B2 JP6153613B2 (ja) 2017-06-28

Family

ID=50150282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528457A Expired - Fee Related JP6153613B2 (ja) 2012-08-23 2013-03-15 乳がん治療を決定する方法

Country Status (7)

Country Link
US (2) US10175240B2 (enExample)
EP (1) EP2888594B1 (enExample)
JP (1) JP6153613B2 (enExample)
AU (1) AU2013306380A1 (enExample)
CA (1) CA2882621A1 (enExample)
ES (1) ES2696202T3 (enExample)
WO (1) WO2014031164A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014002200A2 (pt) 2011-07-29 2017-03-07 Medivation Prostate Therapeutics Inc tratamento de câncer de mama
WO2014031164A1 (en) 2012-08-23 2014-02-27 The Regents Of The University Of Colorado, A Body Corporate Method for determining breast cancer treatment
EP3604556A1 (en) 2014-12-12 2020-02-05 Medivation Prostate Therapeutics LLC Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
CN113490850B (zh) * 2018-08-17 2024-12-06 基因泰克公司 用于治疗乳腺癌的诊断和治疗方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008185A (en) * 1985-11-04 1991-04-16 Cell Analysis Systems, Inc. Methods and apparatus for the quantitation of nuclear proteins
US5292638A (en) * 1990-12-07 1994-03-08 The Regents Of The University Of California Method of determining functional estrogen receptors for prognosis of cancer
AU8821301A (en) 2000-06-28 2002-01-08 Bristol Myers Squibb Co Selective androgen receptor modulators and methods for their identification, design and use
WO2007121459A2 (en) 2006-04-18 2007-10-25 Wellstat Biologics Corporation Detection of steroid receptors on circulating carcinoma cells and treatment
CA2663595A1 (en) 2006-08-07 2008-02-14 The Board Of Regents Of The University Of Texas System Proteomic patterns of cancer prognostic and predictive signatures
EP2065474A1 (en) * 2007-11-28 2009-06-03 Siemens Healthcare Diagnostics GmbH A method to assess prognosis and to predict therapeutic response to endocrine treatment
WO2009137543A2 (en) * 2008-05-06 2009-11-12 Ore Pharmaceuticals Inc. Methods for breast cancer screening and treatment
WO2014031164A1 (en) 2012-08-23 2014-02-27 The Regents Of The University Of Colorado, A Body Corporate Method for determining breast cancer treatment

Similar Documents

Publication Publication Date Title
WO2015082046A3 (de) Substituierte oxepine
KR102369814B9 (ko) 금속판, 금속판의 제조 방법, 및 금속판을 사용하여 마스크를 제조하는 방법
JP2013188229A5 (enExample)
KR102087056B9 (ko) 금속판, 금속판의 제조 방법, 및 금속판을 사용해서 증착 마스크를 제조하는 방법
JP2015503422A5 (enExample)
JP2012030068A5 (enExample)
JP2016037652A5 (enExample)
JP2015186128A5 (enExample)
JP2016540360A5 (ja) 基板処理システム及び基板処理方法
EP2971213A4 (en) IMPROVED ALUMINUM MAGNESIUM LITHIUM ALLOYS AND METHOD FOR THE PRODUCTION THEREOF
JP2013140343A5 (enExample)
JP2016508934A5 (enExample)
EP3073171A4 (en) Heat-insulation film, and heat-insulation-film structure
LT3038656T (lt) Glikozaminoglikano junginys, jo gamybos būdas ir panaudojimas
TWI561508B (en) Onium salt, chemically amplified positive resist composition, and patterning process
HUE055176T2 (hu) Mikrobiális olaj, eljárás mikrobiális olaj elõállítására, töményített mikrobiális olaj és eljárás töményített mikrobiális olaj elõállítására
JP2014513003A5 (enExample)
IL242437B (en) Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process
JP2015529327A5 (enExample)
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
GB2512869B (en) A composite having acoustic properties, manufacturing the composite, a component comprising a composite, manufacturing the component and uses thereof
JP2015521279A5 (enExample)
JP2017077228A5 (ja) 移動式搾乳装置および該移動式搾乳装置を使用した放牧方法
EP2980096A4 (en) 2,3,5-trihydroxy-androst-6-one, as well as method of preparation and use thereof
JP2015009865A5 (enExample)